Keller and Heckman Tobacco and E-Vapor attorneys, led by Partner Azim Chowdhury, co-authored with Latham & Watkins the Food and Drug Law Institute (FDLI) 2026 publication, “Nicotine Delivery Products: Navigating FDA’s Policies and Regulations in a Dynamic Environment.” Counsel Neelam Gill and LieAnn Van-Tull also served as co-authors, while the following Keller and Heckman attorneys
Pennsylvania has joined the growing group of states that condition ENDS sales on federal PMTA status. Enacted as Act 57 of 2025, House Bill 1425 adds Section 206-I to The Fiscal Code and directs the Pennsylvania Attorney General to maintain a directory of electronic cigarettes that may be sold in the Commonwealth. The law ties
We are pleased to announce the agenda for Keller and Heckman’s 10th Annual E-Vapor, Nicotine, and Tobacco Law Symposium, being held Monday, May 4 – Tuesday, May 5, 2026, in Las Vegas, Nevada, right before the CHAMPS Trade Show! Click here to view the full program agenda.
Click here to register and save
On January 9, 2026, China’s top tobacco regulator, the State Tobacco Monopoly Administration (STMA), published Announcement No. 1 of 20261, officially incorporating nicotine pouches and other “smokeless tobacco products” into its regulatory framework. According to the Announcement, “smokeless tobacco products” refer to tobacco products containing nicotine that are used orally, nasally, or externally
Save the date for Keller and Heckman’s 10th Annual E-Vapor, Nicotine, and Tobacco Law Symposium, taking place on May 4 – 5, 2026, in Las Vegas, NV, at the Paris Las Vegas hotel (right before the CHAMPS Trade Show)!
This two-day seminar is designed to provide in-depth knowledge on legal, regulatory, and scientific
On July 17, 2025, the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders (MGOs) to JUUL Labs Inc. (JUUL), authorizing for sale JUUL’s tobacco- and menthol-flavored pod-based electronic nicotine delivery system (ENDS) products in the United States, reversing its previous position and marking a major regulatory milestone in the years-long evaluation of JUUL’s
On April 2, 2025, the U.S. Supreme Court issued its decision in the Wages and White Lion Investments d/b/a Triton Distribution (hereafter “Triton”) Premarket Tobacco Product Application (PMTA) Marketing Denial Order (MDO) challenge. In a 9-0 unanimous ruling, the Supreme Court held that FDA did not act arbitrarily and capriciously when it denied the
A wave of new “Extended Producer Responsibility” or “EPR” programs is beginning to impact companies placing packaged products, including tobacco products, on the market in U.S. states, including California, Colorado, Maine, Minnesota, and Oregon.
The five EPR programs for packaging enacted thus far have different facets. However, at their core
On December 10, 2024, the U.S. Food and Drug Administration (FDA or the Agency) Center for Tobacco Products (CTP) advanced a proposal to set a maximum nicotine level in cigarettes and certain other combusted tobacco products. The Agency requested the White House Office of Management and Budget (OMB) expedite a proposed tobacco product standard in
Keller and Heckman Tobacco and E-Vapor attorneys, led by Partner Azim Chowdhury, co-authored with Latham & Watkins the upcoming Food and Drug Law Institute (FDLI) publication, “Nicotine Delivery Products: Navigating FDA’s Policies and Regulations in a Dynamic Environment.” The following Keller and Heckman attorneys also contributed: Kathryn Skaggs, Neelam Gill, LieAnn Van-Tull, Kelsey Anliker, Josephine
